EBOS Group Ltd. (EBOSF)
EBOS Group Market Cap: 4.828B for Dec. 12, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 59.63M |
| Kazia Therapeutics Ltd. | 17.42M |
| Immutep Ltd. | 375.54M |
| Propanc Biopharma, Inc. | 10.54M |
| Mesoblast Ltd. | 2.312B |
Market Cap Related Metrics
| PE Ratio | 33.61 |
| PS Ratio | 0.5907 |
| Price to Free Cash Flow | 27.13 |
| Price | 23.75 |
| Earnings Yield | 2.98% |
| Operating PE Ratio | 17.08 |
| Normalized PE Ratio | 30.67 |